Willingness-to-pay to access Ingenol Mebutate Gel for Actinic Keratosis Treatment in the U.S. Setting

Willingness-to-pay to access Ingenol Mebutate Gel for Actinic Keratosis Treatment in the U.S. Setting

**Background:** Currently available topical treatments for actinic keratosis (AK) adversely affect patients’ quality of life because of long treatment durations and long-lasting local skin reactions (LSRs), which may result in poor treatment adherence and patient outcomes. Ingenol mebutate gel, a re...

Full description

Saved in:
Bibliographic Details
Main Authors: Michael Willis, Sandra Erntoft, Sofie Persson, Jenny M. Norlin, Ulf Persson
Format: Article
Language:English
Published: Columbia Data Analytics, LLC 2014-10-01
Series:Journal of Health Economics and Outcomes Research
Online Access:https://doi.org/10.36469/9879
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items